Description
ROMK-IN-32 is a renal outer medullary potassium channel (ROMK) inhibitor with an IC50 of 35 nM. ROMK-IN-32 also inhibits hERG with an IC50 of 22 μM.
Product information
CAS Number: 1914944-54-9
Molecular Weight: 452.50
Formula: C24H28N4O5
Chemical Name: 8-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-1, 3-dihydro-2-benzofuran-5-yl)ethyl]-2-(1-methyl-6-oxo-1, 6-dihydropyridazin-3-yl)-2, 8-diazaspiro[4.5]decan-1-one
Smiles: CN1N=C(C=CC1=O)N1CCC2(CCN(C[C@H](O)C3=CC=C4C(COC4=O)=C3C)CC2)C1=O
InChiKey: AEQJLXICIKRMCT-IBGZPJMESA-N
InChi: InChI=1S/C24H28N4O5/c1-15-16(3-4-17-18(15)14-33-22(17)31)19(29)13-27-10-7-24(8-11-27)9-12-28(23(24)32)20-5-6-21(30)26(2)25-20/h3-6,19,29H,7-14H2,1-2H3/t19-/m0/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
ROMK-IN-32 exhibits weak human SERT activity (IC50 10.4 μM; hSERT/hROMK EP=612x).
In Vivo:
ROMK-IN-32 demonstrates blood pressure lowering effects in the spontaneously hypertensive rat model. ROMK-IN-32 exhibits moderate oral bioavailability (78%) following oral administration (1 mg/kg) in WH rats. ROMK-IN-32 exhibits terminal elimination half-lives (rat 4.7 and dog 5.8 h) due to high plasma clearance (9.6 and 18.3 mL/min/kg respectively) combined with large volumes of distribution (3.0 and 5.0 L/kg respectively) following intravenous administration (rat 0.5 and dog 1.0 mg/kg).
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
